Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Canada: The Journal of Psychiatric Research recently reported that childhood cat ownership, particularly with rodent-hunting cats,.
Read Full NewsIn a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?
New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.
A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.
A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.
A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.
1.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
2.
Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.
3.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
4.
Low Income, Education Tied to Depression in Older Adults
5.
improvements in the treatment of prostate cancer resistant to chemotherapy.
1.
Case Study: Artificial Intelligence in Early Cancer Detection
2.
Understanding Neutrophilia: Causes, Symptoms, and Treatment Options
3.
Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms
4.
Understanding Epidural Hematoma: Symptoms, Causes and Treatment
5.
Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
5.
Understanding the causes of anemia in adults beyond nutritional deficiencies
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge